Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roman Vion

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Bulletin Du Cancer|December 31, 2021
Roman Vion, Maxime Fontanilles, Frédéric Di Fiore, et al.
Breast Care (Basel, Switzerland)|June 1, 2023
Associated Factors with Breast Nurses Unplanned Interventions in Patients Treated for an Early Breast CancerRoman Vion, Patricia Fleury, Valérie Blazejewski, et al.
Breast Cancer Research and Treatment|April 22, 2025
Impact of pembrolizumab on ovarian function in young triple-negative breast cancer patients treated with chemo-immunotherapyAnne Perdrix, Nathalie Olympios, Jean Rouvet, et al.
Cancers|October 13, 2021
Lung Cancer Surgery after Treatment with Anti-PD1/PD-L1 Immunotherapy for Non-Small-Cell Lung Cancer: A Case-Cohort StudyKinan El Husseini, Nicolas Piton, Marielle De Marchi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2025
Induction of tertiary lymphoid structures in tumor microenvironment to improve anti-tumoral immune checkpoint blockade efficacyRoman Vion, Matthieu Roulleaux-Dugage, Ronan Flippot, et al.
Frontiers in Oncology|July 23, 2024
Prognostic value of HPV circulating tumor DNA detection and quantification in locally advanced cervical cancerLudivine Beaussire-Trouvay, Orianne Duhamel, Anne Perdrix, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 3, 2025
Prognostic value of circulating HER2 extracellular domain in patients with HER2-positive metastatic breast carcinoma treated with TDM-1 (trastuzumab emtansine)Roman Vion, Céline Calbrix, Anca Berghian, et al.
Breast (Edinburgh, Scotland)|October 18, 2025
The role of body mass index at diagnosis in patients with inflammatory breast cancerKristien Borremans, Ha-Linh Nguyen, Maxim De Schepper, et al.
Cancer Research Communications|December 26, 2023
Treatment Response, Tumor Infiltrating Lymphocytes and Clinical Outcomes in Inflammatory Breast Cancer-Treated with Neoadjuvant Systemic TherapyMaxim De Schepper, Ha-Linh Nguyen, François Richard, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Bulletin Du Cancer|December 31, 2021
Roman Vion, Maxime Fontanilles, Frédéric Di Fiore, et al.
Breast Care (Basel, Switzerland)|June 1, 2023
Associated Factors with Breast Nurses Unplanned Interventions in Patients Treated for an Early Breast CancerRoman Vion, Patricia Fleury, Valérie Blazejewski, et al.
Breast Cancer Research and Treatment|April 22, 2025
Impact of pembrolizumab on ovarian function in young triple-negative breast cancer patients treated with chemo-immunotherapyAnne Perdrix, Nathalie Olympios, Jean Rouvet, et al.
Cancers|October 13, 2021
Lung Cancer Surgery after Treatment with Anti-PD1/PD-L1 Immunotherapy for Non-Small-Cell Lung Cancer: A Case-Cohort StudyKinan El Husseini, Nicolas Piton, Marielle De Marchi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2025
Induction of tertiary lymphoid structures in tumor microenvironment to improve anti-tumoral immune checkpoint blockade efficacyRoman Vion, Matthieu Roulleaux-Dugage, Ronan Flippot, et al.
Frontiers in Oncology|July 23, 2024
Prognostic value of HPV circulating tumor DNA detection and quantification in locally advanced cervical cancerLudivine Beaussire-Trouvay, Orianne Duhamel, Anne Perdrix, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 3, 2025
Prognostic value of circulating HER2 extracellular domain in patients with HER2-positive metastatic breast carcinoma treated with TDM-1 (trastuzumab emtansine)Roman Vion, Céline Calbrix, Anca Berghian, et al.
Breast (Edinburgh, Scotland)|October 18, 2025
The role of body mass index at diagnosis in patients with inflammatory breast cancerKristien Borremans, Ha-Linh Nguyen, Maxim De Schepper, et al.
Cancer Research Communications|December 26, 2023
Treatment Response, Tumor Infiltrating Lymphocytes and Clinical Outcomes in Inflammatory Breast Cancer-Treated with Neoadjuvant Systemic TherapyMaxim De Schepper, Ha-Linh Nguyen, François Richard, et al.
Pageof 1